PATENT CLAIM ANALYSIS

Application Number: 16041483
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "015100"]

Abstract:
The invention relates to the use of an isolated peptide of 10 to 32 amino acid residues in length for the treatment of neural injury, wherein the isolated peptide comprises at least 10 to 22 arginine residues. The peptide may be a poly-arg sequence or an arginine-rich peptide.

Claim (Index 33):
The method of  claim 32 , wherein said patient is administered said polypeptide to treat a neural injury selected from the group consisting of ischemia, perinatal hypoxia-ischemia, Alzheimer's disease, Huntington's Disease, Multiple Sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, neuropathic pain, stroke, peripheral neuropathy, spinal cord injury, pain and epilepsy.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 95.0
- Lexical Diversity: 1.41667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12328625', '12514773', '15745432', '14782912', '13066700']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7981451736919855
- 35 USC 102 Novelty (BERT): 0.5057968760594003
- Combined Prediction Score: 0.7689103439287269
- Mean Citation Score: 249.166218
- Max Citation Score: 266.10522000000003
- Similarity Product: 186.2006421517468

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test